• Sandia’s international peer mentorship program improves management of biorisks

    The world is becoming increasingly interconnected. While this has definite advantages, it also makes it easier to spread disease. Many diseases don’t produce symptoms for days or weeks, far longer than international flight times. For example, Ebola has an incubation period of two to twenty-one days. Improving biosafety practices around the world to prevent the spread of diseases to health care workers and biomedical researchers is an important part of halting or minimizing the next pandemic, said Eric Cook, a Sandia National Laboratories biorisk management expert.

  • $300K challenge to uncover emerging biothreats

    DHS S&T has launched the Hidden Signals Challenge, a $300,000 prize competition that seeks concepts for novel uses of existing data to uncover emerging biothreats. The Challenge calls upon data innovators from a wide variety of fields to develop concepts that will identify signals and achieve timelier alerts for biothreats in our cities and communities.

  • U.S. not prepared to identify perpetrators of biological attacks: Expert panel

    When violent attackers use biological agents to inflict harm, not only must law enforcement attribute the crime to the correct perpetrator, they must also identify the pathogens used and their sources exactly and quickly. That was the focus of a special meeting last week hosted by the Blue Ribbon Study Panel on Biodefense.

  • Proposed budget cuts will weaken state, local ability to handle biological, chemical attacks

    Looming budget cuts within DHS are doing little to qualm concern that state and local infrastructure is unprepared to handle a biological or chemical attack. “We are much better prepared than we were” post-9/11,” said one expert “But we are not where we need to be, and the progress is, in some cases, somewhat fragile.”

  • Biological weapons and virtual terrorism

    Terrorists find biological weapons attractive because these weapons are difficult to detect, are cost effective, and can be easy to use. Aerosols of biological agents are invisible, silent, odorless, tasteless, relatively easily dispersed — and they are 600 to 2000 times cheaper than other weapons of mass destruction. It has been estimated that the cost of a biological weapon is about 0.05 percent the cost of a conventional weapon to produce similar numbers of mass casualties per square kilometer.

  • The Invisible Threat

    In 1995, during the Monday morning rush hour in the Tokyo subway, thousands of commuters inhaled toxic nerve gas left leaking from little plastic bags. Twelve people died, and thousands more were injured in the deadliest attack in Japan since the Second World War. The attack was the work of Japanese cult Aum Shinrikyo. The cult members, many of them students of science, were unsuccessful in launching a true biological attack. They were clumsy and unfocused and the tools too complex to pull off with ease. But those efforts were in the mid-1990s, and the tools for creating bioattacks have become more accessible. The Trump administration, however, is threatening to cut the funding for science needed to defend against such attacks.

  • Nose spray treatment for cyanide poisoning

    The first nose spray treatment for the life-threatening effects of cyanide poisoning will be developed under an agreement between HHS and Response and Emergent BioSolutions of Gaithersburg, Maryland. The treatment is needed because cyanide could be used as a chemical weapon against the United States, according to the agency.

  • Cleaning up subways after release of biological warfare agent such as anthrax

    If you’re like most people, you don’t spend much time thinking about what would happen if anthrax was released into your local subway system. But Sandia Lab engineer Mark Tucker has spent much of the past twenty years thinking about incidents involving chemical or biological warfare agents, and the best ways to clean them up. Tucker’s current project focuses on cleaning up a subway system after the release of a biological warfare agent such as anthrax.

  • Lax policies governing dual-use research, scientists unaware of research’s biosecurity implications

    The National Academies of Sciences has examined policies and practices governing dual-use research in the life sciences – research that could potentially be misused to cause harm – and its findings identify multiple shortcomings. While the United States has a solid record in conducting biological research safely, the policies and regulations governing the dissemination of life sciences information that may pose biosecurity concerns are fragmented. Evidence also suggests that most life scientists have little awareness of biosecurity issues, the report says, stressing the importance of ongoing training for scientists.

  • Map shows how to disable dangerous bioweapon

    The Centers of Disease Control (CDC) ranks tularemia as one of the six most concerning bioterrorism agents, alongside anthrax, botulism, plague, smallpox and viral hemorrhagic fever. And Russian stockpiles of it likely remain. American scientists studying F. tularensis recently mapped out the complex molecular circuitry that enables the bacterium to become virulent. The map reveals a unique characteristic of the bacteria that could become the target of future drug development.

  • New biosecurity initiative to advance benefits, reduce risks of life sciences research

    A new biosecurity initiative at Stanford’s Freeman Spogli Institute for International Studies (FSI) aims to identify and mitigate biological risks, both natural and man-made, and safeguard the future of the life sciences and associated technologies. The biosecurity initiative will seek to advance the beneficial applications of the life sciences while reducing the risks of misuse by promoting research, education and policy outreach in biological security.

  • Biosecurity and synthetic biology: it is time to get serious

    Synthetic biology has only been recently recognized as a mature subject in the context of biological risk assessment — and the core focus has been infectious diseases. In the case of biosecurity, we’re already dependent on biology [with respect to food, health etc.] but we still have an opportunity to develop biosecurity strategies before synthetic biology is ubiquitous. There is still an opportunity to act now and put norms and practices in place because the community is still relatively small. “If scientists are not taking care of biosecurity now, other people will start taking care of it, and they most likely will start preventing researchers from doing good science.”

  • Distinguishing virulent from harmless bacteria to help biological surveillance

    Biological “detectives” are tracking down biothreats such as the bacteria that causes tularemia (“rabbit fever”), but they constantly face the challenge of avoiding false positives. Sounding the alarm over a bioattack, only to find it’s a harmless relative in the same genus, reduces credibility and public trust. Researchers are narrowing down the confusion over Francisella bacteria, a few species of which include highly virulent human and animal pathogens, fish pathogens, opportunistic human pathogens, tick endosymbionts, and free-living isolates inhabiting brackish water.

  • Identifying vulnerabilities posed by synthetic biology

    Given the possible security vulnerabilities related to developments in synthetic biology – a field that uses technologies to modify or create organisms or biological components – a new report by the National Academies of Sciences proposes a framework to identify and prioritize potential areas of concern associated with the field. “While biotechnology is being pursued primarily for beneficial and legitimate purposes, there are potential uses that are detrimental to humans, other species, and ecosystems,” says one of the report’s authors.

  • Making gene editing safer

    Gene editing technologies have captured increasing attention from healthcare professionals, policymakers, and community leaders in recent years for their potential to cure disease, control mosquito populations, and much more. The potential national security applications and implications of these technologies are equally profound, including protection of troops against infectious disease, mitigation of threats posed by irresponsible or nefarious use of biological technologies, and enhanced development of new resources derived from synthetic biology, such as novel chemicals, materials, and coatings with useful, unique properties. DARPA is funding the efforts of seven teams aiming to develop new knowledge and tools to support responsible innovation in gene editing and protect against threats to genome integrity.